×

Error message

The file could not be created.

Public Policy Resources

Share

Group Letter on Comparative Effectiveness Considerations for Selected Oncology Drugs

October 2, 2023

ACS CAN and partner organizations provided comments on the Medicare Drug Price Negotiation Program: Considerations for Selected Oncology Drugs.

PDF icon FINAL-Group Letter on Comparative Effectiveness Considerations for Selected Oncology Drugs 10-2-23

Related Resources

Prescription Drug Affordability Boards and the Impact on Cancer Care

October 4, 2024

ACS CAN has long fought for public policies that support the availability and affordability of medically necessary prescription drugs. 

Read more

ACS CAN Comments re: Removing Medical Debt from Credit Reports

August 9, 2024

ACS CAN submitted comments to the Consumer Financial Protection Bureau strongly supporting the proposal to prohibit medical debt from appearing on credit reports.

Read more